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This study was performed to characterize the
mechanism of choline transport into human keratino-
cytes. Uptake of [3H]choline was measured both in
the HaCaT cell line and in native keratinocytes.
Uptake in HaCaT cells was linear with time at least
up to 10 min. There was little dependence of choline
transport on sodium. Choline uptake was slightly
stimulated by extracellular H+ with the pH optimum
being 7.5. The uptake rate was saturable and indi-
cated participation of a single transport system
(Kt = 14.8 6 1.0 mM, Vmax = 1.0 6 0.01 nmol per
10 min per mg protein). The choline uptake into
HaCaT cells was inhibited by unlabeled choline,
hemicholinium-3, and acetylcholine. The proto-
typical organic cation tetraethylammonium showed
very little af®nity for the choline uptake system in
these cells. Several cationic drugs such as diphen-
hydramine, clonidine, and atropine also interacted
with the transport system. Choline uptake in normal
keratinocytes was very similar to that in HaCaT cells
with respect to substrate speci®city and af®nity. We
conclude that keratinocytes express a Na+ indepen-
dent, high-af®nity choline transport system. This
system accepts many pharmacologically important
organic cations as substrates. It is similar or identical
to the choline carrier described in intestinal epithelial
cells and in endothelial cells of the blood±brain bar-
rier. The choline carrier seems to have relevance not
only for the uptake of cationic drugs into the
keratinocytes but also for the biosynthesis of skin
lipids. Key words: choline transport/drug delivery/HaCaT
cells/keratinocytes/skin. J Invest Dermatol 119:118±121,
2002
B
ecause of limited capacities for choline synthesis in
several organs, choline is considered a dietary require-
ment, a partial vitamin in some animals, including
humans (Zeisel, 2000). Choline is essential for the
synthesis of the major membrane phospholipid phos-
phatidylcholine. Moreover, it serves as a precursor to the synthesis of
the neurotransmitter acetylcholine. The synthesis of phosphatidyl-
choline and acetylcholine occurs intracellularly. Therefore, choline
has to be transported from the extracellular compartment across the
cell membrane into the cells. Such membrane transport processes of
choline have extensively been studied during the last several years,
e.g., the transport at the intestinal epithelium (Saitoh et al, 1992), the
renal tubules (Ullrich, 1997), ®broblasts (Schloss et al, 1994), neurons
(Okuda et al, 2000), endothelial cells of the blood±brain barrier
(Friedrich et al, 2001), placenta (Grassl, 1994; Eaton and Sooranna,
1998), and others. It has been shown that cultured skin ®broblasts
express a high-af®nity choline uptake system (Maltese and Doucette,
1988). There are no detailed studies on choline transport in
keratinocytes. This is surprising especially as it has been shown that
choline is required by human epidermal keratinocytes for optimal
proliferation and differentiation (Gordon et al, 1988). In keratino-
cytesÐas in all cellsÐcholine added to cytidine diphosphate reacts
with diglycerides to phosphatidylcholine (lecithin biosynthesis) or
with ceramides to form sphingomyelin (Wieder et al, 1995). As to
the second function of choline it has been found that epidermal
keratinocytes synthesize and secrete acetylcholine. This ``neuro-
transmitter'' itself works in the epidermis as a local hormone (Grando
et al, 1993). For example, it modulates Ca2+ transport into
keratinocytes via cholinergic cell-surface receptors.
This study was initiated to characterize the uptake of choline into
human keratinocytes. As an organic cation, choline is a substrate for
carriers of the family of organic cation transporters. Since 1994
several members of this family have been cloned from different
tissues (OCT1, OCT2, OCT3: GruÈndemann et al, 1994; for
review see Koepsell, 1998; Burckhardt and Wolff, 2000; Dresser
et al, 2001). OCT1 and OCT2 accept choline as a substrate with
comparatively low af®nity (620 mM and 210 mM, respectively;
Gorboulev et al, 1997). The Na+-dependent high-af®nity choline
transport system CHT1 has been cloned recently (Okuda et al,
2000). CHT1 is the functionally known choline transporter
described at cholinergic neuronal membranes. In several tissues
additional, not yet identi®ed, speci®c transport system(s) for choline
exist. Enterocytes express a speci®c, Na+-independent, pH-inde-
pendent saturable high-af®nity transport system for choline and its
related small quaternary ammonium compounds in their apical
membranes (Saitoh et al, 1992; Koepsell, 1998). The molecular
identity of the system is not yet clear. Similarly, at the blood±brain
barrier, choline is taken up by a Na+-independent high-af®nity
carrier. Friedrich et al (2001) characterized the choline transport in
the blood±brain barrier endothelial cell line RBE4 in detail. They
demonstrated that choline is taken up into these cells by a speci®c
transporter that is not OCT1, OCT2, OCT3, or CHT1.
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Choline transport in skin cells is not only physiologically
relevant, it is very likely of pharmacologic importance. In addition
to choline, not only several other physiologically occurring organic
cations considered biologically active in the integument, such as
dopamine, norepinephrine, serotonin, and histamine, but also
organic cationic drugs such as diphenhydramine, clonidine, and
atropine are potential substrates for organic cation transporters.
The results of this study show that human keratinocytesÐboth
HaCaT cells as well as normal keratinocytes in primary cultureÐ
express a Na+-independent, high-af®nity choline transport system.
This system accepts many pharmacologically important organic
cations as substrates. It is very similar or even identical to the
choline carrier described in intestinal epithelial cells and in
endothelial cells of the blood±brain barrier.
MATERIALS AND METHODS
Materials Cell culture media and supplements and trypsin solution
were purchased from Life Technologies (Karlsruhe, Berlin, Germany),
fetal bovine serum from Biochrom AG (Karlsruhe, Berlin, Germany).
[Methyl-3H]choline chloride (speci®c activity 81 Ci per mmol) was
obtained from Amersham International (Amersham, U.K.). Choline,
acetylcholine, atropine, guanidine, diphenhyramine, tetraethylammonium
(TEA), thiamine, histamine, scopolamine, and lidocaine were purchased
from Sigma (Deisenhofen, Germany). Clonidine, hemicholinium-3, and
carbachol were from ICN (Heidelberg, Germany). All other chemicals
were of analytical grade.
Cell culture HaCaT cells (passages 33±75) established by Boukamp et al
(1988) were routinely cultured in 75 cm2 culture ¯asks with Dulbecco's
modi®ed Eagle medium supplemented with 10% fetal bovine serum,
gentamicin (44 mg per ml), 1% glutamine, and calcium solution
(0.09 mM). The Dulbecco's modi®ed Eagle medium used contains
choline at a concentration of 28.7 mM. In complete medium the choline
concentration is expected to be about 30 mM. Subcon¯uent cultures
were treated for 5 min with Dulbecco's phosphate-buffered saline
followed by a 2 min incubation with 0.05% trypsin±0.02% ethylene-
diamine tetraacetic acid solution. For most experiments, the cells were
seeded on to 35 mm disposable Petri dishes (Becton Dickinson, U.K.) at
a density of 0.8 3 106 cells per dish. The uptake measurements were
performed on the ®fth day after con¯uence. Normal keratinocytes were
isolated from neonatal foreskins according to the standard procedure
described by Life Technologies and cultured in serum-free keratinocyte
medium supplemented with bovine pituitary extract (25 mg per ml) and
recombinant epidermal growth factor (0.1 ng per ml). Subcon¯uent cells
were washed with Dulbecco's phosphate-buffered saline and isolated
using trypsin-ethylenediamine tetraacetic acid at 37°C. Cells were seeded
at passage 2 at a cell density of 0.12 3 106 cells per dish. The uptake
measurements were performed on days 13±14 after seeding.
Transport studies Uptake of [3H]choline in cells cultured on plastic
dishes was measured at room temperature (Brandsch et al, 1993; KnuÈtter
et al, 2001). In most cases, the uptake buffer contained 25 mM HEPES/
Tris (pH 7.5), 140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.8 mM
MgSO4, 5 mM glucose, and 3 nM [
3H]choline, and increasing
concentrations of unlabeled substances (0±31.6 mM). After incubation
for mostly 10 min, the cells were quickly washed four times with ice-
cold buffer, solubilized with 1 ml of a lysis buffer containing 50 mM
Tris, 140 mM NaCl, 1.5 mM MgSO4, and 0.5% Igepal-Ca-630 and
0.2% sodium dodecyl sulfate, and prepared for liquid scintillation
spectrometry.
Data analysis Experiments were done in duplicate or triplicate and
each experiment was repeated two to three times. Results are given as
mean 6 SEM. IC50 values (i.e., concentration of the unlabeled
compounds necessary to inhibit 50% of [3H]choline carrier-mediated
uptake) were determined by nonlinear regression using the four
parameter logistic equation (linear dose vs effect) y = min + (max ±
min)/(1 + (X/IC50)
±P) where max is the initial y-value (= 100%), min
the ®nal y-value (= 2.3%) and the power P represents Hill coef®cient
(= 1).
RESULTS AND DISCUSSION
To determine whether keratinocytes take up choline by a carrier-
mediated process, we ®rst investigated the functional characteristics
of choline uptake in cells of the immortalized keratinocyte line
HaCaT. The uptake of [3H]choline into cells grown as con¯uent
monolayers on impermeable supports was measured. Figure 1
describes the time course of [3H]choline uptake into HaCaT cells
from an uptake medium that contained NaCl and from a medium
in which NaCl was replaced by LiCl. The uptake was linear with
time at least for up to 10 min. There was little dependence of
choline uptake on Na+. [3H]Choline uptake was found to be
markedly reduced by changing the extracellular pH from 7.5 to 5.5
(Fig 2). An extracellular pH of 7.5 represents the optimum for the
[3H]choline uptake. Uptake could not be further stimulated by
increasing the extracellular pH to 8.0 or 8.5. Interestingly, a very
similar pH pro®le was observed for the choline transport in
endothelial cells of the blood±brain barrier (Friedrich et al, 2001).
Based on the results presented in Figs 1 and 2, subsequent
experiments were performed using a 10 min incubation period in
the presence of 140 mM NaCl at a extracellular pH of 7.5.
The dependence of the choline uptake rate on the substrate
concentration was investigated to determine the kinetic parameters
of the transport system (Fig 3). Uptake rates were measured over a
substrate concentration range of 1 mM±1 mM. Carrier-mediated
uptake, which was calculated by subtracting the nonmediated
component from the total uptake, was used in the kinetic analysis.
Figure 1. Time course of [3H]choline uptake in HaCaT cells.
Uptake of [3H]choline (3 nM) was measured in buffer (pH 7.5)
containing NaCl 140 mM (closed circles) or LiCl 140 mM (open
circles). Data are shown as mean 6 SEM, n > 4.
Figure 2. Effect of pH on [3H]choline uptake in HaCaT cells.
Uptake of [3H]choline (3 nM) was measured in buffer with different pH
values containing NaCl 140 mM for 10 min. Data are shown as
mean 6 SEM, n > 4.
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The nonmediated component, which represents diffusion plus
binding, was determined from the uptake of [3H]choline in the
presence of excess amount (20 mM) of unlabeled choline. This
component was 2.3% of total uptake at 3 nM of [3H]choline. The
relationship between carrier-mediated uptake rate and substrate
concentration was found to be hyperbolic, indicating saturability of
the transport system. When the results were expressed in the form
of an Eadie±Hofstee plot (uptake rate/substrate concentration vs
uptake rate), a straight line (r2 = 0.989) was obtained (Fig 3, inset).
The apparent Michaelis±Menten constant (Kt) was 14.8 6 0.1 mM
and the maximal velocity (Vmax) was 1.04 6 0.1 nmol per 10 min
per mg protein. The kinetic parameters are very similar to that of
the choline transport system at blood±brain barrier cells where a Kt
value of 23 mM and a maximal velocity of transport of 0.5 nmol per
10 min per mg protein have been determined (Friedrich et al,
2001). In HaCaT cells (as in RBE4 cells) there was no evidence for
the presence of a second saturable transport system. We cannot rule
out, however, the presence of an additional, but kinetically
indistinguishable carrier-mediated process.
We investigated the substrate selectivity of the system that is
responsible for the choline uptake in HaCaT cells. This was done
by measuring the ability of several physiologically and pharmaco-
logically active organic cations (1 mM) to inhibit the uptake of
[3H]choline (3 nM, 10 min, pH 7.5). [3H]Choline uptake was
strongly inhibited by unlabeled choline, hemicholinium-3, acetyl-
choline, guanidine, thiamine, clonidine, and diphenhydramine
(Fig 4). There was a moderate inhibition by carbachol and atropine
and only a weak inhibition by TEA, scopolamine, and lidocaine.
Histamine was not recognized by the choline transport system.
Figure 5 shows the dose±response relationship of six compounds
for the inhibition of choline uptake. From these curves, we
determined the inhibitory concentrations (IC50). The highest
af®nity to the transport system displays choline (9.7 6 0.2 mM)
followed by diphenhydramine (85 6 3 mM), acetylcholine (104 6
12 mM), guanidine (223 6 11 mM), carbachol (677 6 11 mM),
and atropine (1230 6 80 mM).
To the best of our knowledge, nothing is known so far about the
presence of organic cation transporters in keratinocytes. Because of
the af®nity constants, the choline transport reported here does not
appear to be mediated by OCT1 or OCT2. OCT1 and OCT2
accept choline with af®nity constants of 620 mM and 210 mM,
respectively (Gorboulev et al, 1997). TEA, a prototypical organic
cation very often used as a high-af®nity reference compound for
OCT1, OCT2, and OCT3, displays af®nity constants at OCT1
and OCT2 of 76 mM and 95 mM, respectively (Gorboulev et al,
1997). In our study, TEA interacts with the choline transport
system with a very low af®nity (24% inhibition at a concentration
of 1 mM, Fig 4). Again, the same pattern was observed at
endothelial cells of the blood±brain barrier where the IC50 constant
of TEA at the choline transport system described in that study was
approximately 10 mM (Friedrich et al, 2001).
HaCaT cells are human keratinocytes immortalized spontan-
eously (Boukamp et al, 1988). To con®rm that the choline transport
system expressed in HaCaT cells is present in normal, nontrans-
formed keratinocytes we studied choline transport in normal
keratinocytes in primary culture. Figure 6 shows the substrate
speci®city of [3H]choline transport determined in these cells. The
extent of inhibition of [3H]choline transport by choline, acetylcho-
line, TEA, and diphenhydramine corresponds very well to the data
obtained with HaCaT cells. The af®nity constant of choline
determined in normal keratinocytes was 13 6 1 mM (dose±
response data not shown). Again, this value agrees very well with
the af®nity constant of choline in HaCaT cells. Therefore, we
conclude that the choline transporter characterized in this study is
expressed in normal keratinocytes of the human skin. The system is
very likely responsible for the uptake of choline from the blood
into the keratinocytes where it serves as a precursor for the synthesis
of acetylcholine and phosphatidylcholine. The Michaelis±Menten
Figure 4. Substrate speci®city of [3H]choline uptake in HaCaT
cells. Uptake was measured at pH 7.5 for 10 min. Concentration of
inhibitors was 1 mM. Data are shown as mean 6 SEM, n = 4.
Figure 5. Dose±response relationship for the inhibition of
[3H]choline uptake by various organic cations in HaCaT cells.
Uptake of [3H]choline (3 nM) was measured in the absence (control) or
presence of increasing concentrations of various organic cations at
pH 7.5 for 10 min. The results are shown as mean 6 SEM, n > 4.
Figure 3. Saturation kinetics of choline uptake in HaCaT cells.
Uptake of [3H]choline (3 nM) in presence of increasing concentrations
of unlabeled choline was measured at pH 7.5 for 10 min. The results are
shown as mean 6 SEM, n > 4, after subtraction of the nonmediated
component of transport ([3H]choline uptake in presence of 20 mM
unlabeled choline). Inset: Eadie-Hofstee plot.
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constant of 15 mM determined in this study seems to re¯ect the
physiologic concentration. The normal plasma concentration of
choline does not exceed 25 mM (Besseghir et al, 1981).
Interestingly, the optimal range of choline concentration for
proliferation of human keratinocytes fell between 36 mM and
180 mM the optimal choline concentration being 36±72 mM
(Gordon et al, 1988). Phospholipids may be limiting factors in
epidermal turnover and wound healing. The authors suggest that
choline esteri®cation and not methylation of phosphatidylethanol-
amine is the predominant pathway in the biosynthesis of
phosphatidylcholine in keratinocytes. Therefore, choline can
become a speci®c limiting nutrient for keratinocyte proliferation.
Assuming that the choline transport system described in this study is
the major mechanism for choline uptake into the cell under
physiologic conditions, the transporter activity is of crucial
importance for the biosynthesis of skin lipids, such as phosphat-
idylcholines. Further studies using speci®c inhibitors of the
transport protein are needed to test this hypothesis. Interestingly,
the choline requirement was speci®c for keratinocytes. Dermal
®broblasts and epidermal melanocytes were not affected by choline
supplementation (Gordon et al, 1988).
The choline transport system described here might also be of
pharmacologic relevance. The system recognizes the biologically
and/or pharmacologically active organic cations acetylcholine,
guanidine, thiamine, clonidine, diphenhydramine, carbachol, and
atropine. It has to be determined in further studies whether the
cationic drugs are indeed transported into the keratinocytes via the
blood stream or even via the dermal route.
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